Oerth Bio

About:

Oerth Bio is a agriculture-focused biotech firm.

Top Investors: Arvinas, Leaps by Bayer

Description:

Oerth Bio is a developer of targeted protein degraders for agricultural applications. The company leverages Arvinas' novel PROTAC protein degrader technology to develop new human therapeutics for patients with cardiovascular, oncological, and gynecological diseases.

Total Funding Amount:

$55M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2019-01-01

Founders:

John W. Dombrosky

Number of Employees:

11-50

Last Funding Date:

2020-02-27

IPO Status:

Private

Industries: